JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB99818

Anti-Human IgG4 pFc’ [HP6023] (Biotin)

Anti-Human IgG4 pFc’ [HP6023] (Biotin)

Be the first to review this product! Submit a review

|

(3 Publications)

Anti-Human IgG4 pFc’ [HP6023] (Biotin) is a secondary antibody that is suitable for Western blot, IHC, ICC/IF, ELISA and more.

- Reacts with the pFc’ portion of the heavy chain of Human IgG4

查看别名

Immunoglobulin heavy constant gamma 4, Ig gamma-4 chain C region, IGHG4

1 Images
ELISA - Anti-Human IgG4 pFc’ [HP6023] (Biotin) (AB99818)
  • ELISA

Supplier Data

ELISA - Anti-Human IgG4 pFc’ [HP6023] (Biotin) (AB99818)

ELISA - Anti-Human IgG4 pFc [HP6023] (Biotin) (ab99818)

ELISA plate was coated with purified human IgG1, IgG2, IgG3, and IgG4.

Immunoglobulins were detected with serially diluted ab99818 followed by Streptavidin-HRP.

不同偶联物与剂型 (4)

  • Unconjugated

    Anti-Human IgG4 pFc’ [HP6023]

  • 519 FITC

    Anti-Human IgG4 pFc’ [HP6023] (FITC)

  • Alkaline Phosphatase

    Anti-Human IgG4 pFc’ [HP6023] (Alkaline Phosphatase)

  • 578 PE

    Anti-Human IgG4 pFc’ [HP6023] (PE)

关键信息

宿主种属

Mouse

靶标种属

Human

靶标亚型

IgG4

靶标特异性

Fc region

最低交叉反应
预吸附

No

偶联物

Biotin

激发波长/发射波长
应用

IHC-Fr, WB, ELISA, Dot, ICC/IF

applications

克隆

Monoclonal

克隆号

HP6023

亚型

IgG3

轻链类型

kappa

免疫原

Full Length Protein corresponding to Human IGHG4. The exact immunogen used to generate this antibody is proprietary information.

P01861

特异性

ab99818 reacts with the pFc’ portion of the heavy chain of Human IgG4.

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "Dot": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p>for Dot and slot immunoblotting.</p>" }, "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "ICC/IF": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "IHC-Fr": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "ELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/1000 - 1/2000", "notes":"<p></p>" } } }

产品详情

This antibody reacts with the pFc' region of Human IgG4

When it comes to advancing your immunohistochemistry (IHC) research, Abcam offers comprehensive suite of IHC kits and secondary antibodies, designed to deliver precise and reliable results.

性能和储存信息

形式
Liquid
纯化工艺
Affinity purification Protein A
存储溶液
pH: 7.4 Preservative: 0.1% Sodium azide Constituents: PBS
运输条件
Blue Ice
推荐的短期储存条件
+4°C
推荐的长期储存条件
+4°C
储存信息
Store in the dark

产品实验方案

靶点信息

Constant region of immunoglobulin (Ig) heavy chains. Igs are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound Igs serve as receptors, which upon binding to a specific antigen trigger the clonal expansion and differentiation of B lymphocytes into Ig-secreting plasma cells. Secreted Igs known as antibodies mediate the effector phase of humoral immunity by blocking the interaction of infectious antigens with cellular receptors (via the antigen-binding region) and eliciting effector mechanisms that lead to pathogen neutralization (via the constant region) (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The antigen-binding region is formed by the variable domain of one heavy chain paired with the variable domain of its associated light chain. Each Ig molecule has two antigen-binding sites with remarkable affinity for a particular antigen due to V-(D)-J rearrangement, somatic hypermutations and affinity maturation of the variable domains upon antigen exposure (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The constant region defines the Ig isotype that perform distinct sets of effector functions. B cells diversify and rearrange their Ig constant regions through class-switch recombination, a process by which the constant region is switched from one Ig isotype to another, namely from IgM and IgD to IgG, IgA and IgE (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The constant region interacts (via the fragment crystallizable, Fc) with the Fc receptors on innate immune cells to mediate humoral effector functions. Ig gamma-4 (IgG4) isotype does not elicit antibody-dependent cellular cytotoxicity (ADDC) or complement-dependent cytotoxicity (CDC). Instead it is likely involved in immune tolerance mechanisms to allergens and parasites either by blocking IgE-antigen complex formation or by directly inhibiting mast cell degranulation through Fc receptor signaling. In the context of tumorigenesis, it may participate in immunosuppressive mechanisms.
See full target information IGHG4

文献 (3)

Recent publications for all applications. Explore the full list and refine your search

Antibody therapeutics 6:38-48 PubMed36683766

2023

Preclinical evaluation of IAP0971, a novel immunocytokine that binds specifically to PD1 and fuses IL15/IL15R complex.

Applications

Unspecified application

Species

Unspecified reactive species

Jihong Chen,Ziyou Shen,Xiaoling Jiang,Zhenzhen Huang,Chongbing Wu,Dongcheng Jiang,Liusong Yin

JCI insight 6: PubMed34582377

2021

Antibody effector analysis of prime versus prime-boost immunizations with a recombinant measles-vectored chikungunya virus vaccine.

Applications

Unspecified application

Species

Unspecified reactive species

Roland Tschismarov,Raphaël M Zellweger,Min Jie Koh,Yan Shan Leong,Jenny G Low,Eng Eong Ooi,Christian W Mandl,Katrin Ramsauer,Ruklanthi de Alwis

Haemophilia : the official journal of the World Federation of Hemophilia 24:487-491 PubMed29461004

2018

Effects of pre-analytical heat treatment in factor VIII (FVIII) inhibitor assays on FVIII antibody levels.

Applications

Unspecified application

Species

Unspecified reactive species

B Boylan,C H Miller
View all publications

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com